PLSCR5-AS1

Across TCGA pan-cancer cohorts, PLSCR5-AS1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated PLSCR5-AS1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher PLSCR5-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PLSCR5-AS1 expression acts as an unfavorable survival marker.

SKCM, UCEC, and ACC are the cancer types where PLSCR5-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.258	0.789	<.001	48	view →
UCEC	OS	Tertile	All	0.676	0.876	.027	36	view →
ACC	DFS	Tertile	All	0.089	0.666	.017	18	view →
LUSC	OS	Tertile	III,IV	0.126	0.663	.046	18	view →
LIHC	OS	Tertile	All	0.164	0.704	.025	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

PLSCR5-AS1–SKCM (OS)

Open the SKCM breakdown →